78214 Federal Register / Vol. 71, No. 249 / Thursday, December 28, 2006 / Notices 

Place: National Institutes of Health, 

6116 Executive Boulevard, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Barbara Guest, 

Executive Secretary, Office of Liaison 

Activities, National Cancer Institute, 

National Institutes of Health, 6116 

Executive Boulevard, Room 2202, 

Bethesda, MD 20892–8324, 301–496–

0307, guestb@mail.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/dclg/ 

dclg.htm, where an agenda and any 

additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395 Cancer Treatment 

Research; 93.396, Cancer Biology Research; 

93.397, Cancer Centers Support; 93.398, 

Cancer Research Manpower; 93.399, Cancer 

Control, National Institutes of Health, HHS) 

Dated: December 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9884 Filed 12–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SBIR 

Topic 230 (Phases I and II). 

Date: February 27, 2007. 

Time: 12 pm to 4 pm. 

Agenda: To review and evaluate 

contract proposals. 

Place: National Institutes of Health, 

6130 Executive Blvd., Conference Room 

D, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Kenneth L Bielat, 

PhD., Scientific Review Administrator, 

Division Of Extramural Activities, 

National Cancer Institute, 6116 

Executive Boulevard, Room 7147, 

Bethesda, MD 20892, (301)496–7576, 

bielatk@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 20, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9886 Filed 12–2–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute, Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

February 13, 2007, 8:00 a.m. to February 

15, 2007, 5 p.m., Hyatt Regency 

bethesda, One Bethesda Metro Center, 

7400 Wisconsin Avenue, Bethesda, MD, 

20814 which was published in the 

Federal Register on November 30, 2006, 

71 FR 69211. 

The meeting notice is changed to 

reflect the name of the committee from 

‘‘SPORE II’’ to ‘‘SPORE in Prostate, 

Breast and Skin Cancer.’’ The meeting is 

closed to the public. 

Dated: December 20, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9888 Filed 12–28–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of 

Meeting 

Purusant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Child Health and 

Human Development Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National 

Advisory Child Health and Human 

Development Council. 

Date: January 25, 2007. 

Open: 8:00 a.m. to 12:15 p.m. 

Agenda: (1) A report by the Director, 

NICHD; (2) a report of the Subcommittee 

on Planning and Policy; (3) a 

Reproductive Sciences Branch 

Presentation; and other business of the 

Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C–Wing, 

Conference Room 6, Bethesda, MD 

20892. 

Closed: 1:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C–Wing, 

Conference Room 6, Bethesda, MD 

20892. 

Contact Person: Yvonne T. Maddox, 

PhD., Deputy Director, National 

Institute of Child Health and Human 

Development, NIH, 9000 Rockville Pike 

MSC 7510, Building 31, Room 2A03, 

Bethesda, MD 20892, (301) 496–1848. 

Any interested person may file 

written comments with the committee 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 71, No. 249 / Thursday, December 28, 2006 / Notices 78215 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for 

entrance onto the NIH campus. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors will be asked to show 

one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nichd.nih.gov/about/nachhd.htm, 

where an agenda and any additional 

information for the meeting will be 

posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: December 19, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9885 Filed 12–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institutes of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National 

Institute of Child Health and Human 

Development Special Emphasis Panel, 

Mentored Research Scientist 

Development Award. 

Date: January 5, 2007. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

6100 Executive Boulevard, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person:Sathasiva B. 

Kandasamy, PhD., Scientific Review 

Administrator, Division of Scientific 

Review, National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Room 5B01, 

Bethesda, MD 20892–9304, (301) 435–

6680, skandasa@mail.nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

Name of Committee: National 

Institute of Child Health and Human 

Development Special Emphasis Panel, 

Mentored Patient-Oriented Research 

Career Development Award. 

Date: January 11, 2007. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

6100 Executive Boulevard, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person:Sathasiva B. 

Kandasamy, PhD., Scientific Review 

Administrator, Division of Scientific 

Review, National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Room 5B01, 

Bethesda, MD 20892–9304, (301) 435–

6680, skandasa@mail.nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: December 20, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9889 Filed 12–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for 

Scientific Review Special Emphasis 

Panel, Drug Discovery. 

Date: January 3, 2007. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

6701 Rockledge Drive, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Mary Custer, PhD., 

Scientific Review Administrator, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

4180, MSC 7850, Bethesda, MD 20892, 

(301) 435–1164, custerm@csr.nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

Name of Committee: Immunology 

Integrated Review Group, 

Transplantation, Tolerance, and Tumor 

Immunology Study Section. 

Date: January 24–25, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Radisson Clearwater Central, 

20967 US Highway 19 North, 

Clearwater, FL 33765. 

Contact Person: Cathleen L. Cooper, 

PhD., Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge 

Drive, Room 4208, MSC 7812, Bethesda, 

MD 20892, 301–435–3566, 

cooperc@csr.nih.gov. 

Name of Committee: Center for 

Scientific Review Special Emphasis 

Panel, Member Conflict: 

Psychopharmacology. 

Date: January 24–25, 2007. 

Time:9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

6701 Rockledge Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Christine L. Melchior, 

PhD., Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge 


sroberts on PROD1PC70 with NOTICES